Frontiers12d
Low Endogenous LH on the COS Initiation Day of a GnRH-Agonist Regimen Increases the Risk of Early Pregnancy Loss and Adverse ART Outcomes
For the multivariate logistic regression ... All rates were calculated based on the clinical pregnancy. Figure 2 Scatter plot of LH concentrations on the COS initiation day and hCG trigger day. The ...
Frontiers19d
Sprayable solutions containing sticky rice oil droplets reduce western flower thrips damage and induce changes in Chrysanthemum leaf chemistry
In the plants sprayed with RGO there was a considerable overlap in the multivariate plots at 25 days post infestation. A first explanation for this overlap may be that the RGO application induced a ...
GitHub20d
README.md
Histograms are used for continuous variables, while bar charts are used for categorical variables. Multivariate Plots: Multivariate plots show the relationship between multiple variables. Interaction ...
The EMBO Journal5d
Proteogenomic analysis reveals adaptive strategies for alleviating the consequences of aneuploidy in cancer
Aneuploidy is frequent in cancer, but in vitro it triggers multiple cellular stresses and often delays proliferation. Through ...
thorax.bmj6d
Inflammation in preschool cystic fibrosis is of mixed phenotype, extends beyond the lung and is differentially modified by CFTR modulators
Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...
eLife10d
HERV activation segregates ME/CFS from fibromyalgia while defining a novel nosologic entity
Abstract Research of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Fibromyalgia (FM), two acquired chronic illnesses affecting mainly females, has failed to ascertain their frequent ...
eLife8d
Orexin population activity precisely reflects net body movement across behavioral and metabolic states
This important study shows that the activity of hypothalamic hypocretin/orexin neurons (HONs) correlates with body movement over multiple behaviors. Sophisticated techniques and analyses showcase this ...
pharmaphorum2d
J&J plots filings after psoriasis drug clears phase 3 test
Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra (fo ...